$91.11−1.85 (−1.99%)
At close: Nov 17, 2026, 4:00 PM ET· NYSE · USD
Ingredion (INGR) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
Sources Company filings FilingsHow we compute thisNot investment advice
Business engineChoppy: revenue fell 2.8% in FY25, net margin 10.1%; free cash flow runs at 69% of net income. Check the accrual gap.
The four lines that matter · FY21–FY25
Revenue ($M)▼2.8%
7,219.0
FY21→FY25CAGR +1.2%/yr
Net income ($M)▲12.7%
729.0
one-off year: see footnoteCAGR +55.4%/yr
Free cash flow ($M)▼55.2%
511.0
FY21→FY25CAGR +53.5%/yr
Diluted EPS▲15.1%
11.18
buyback-liftedCAGR +59.4%/yr
What the receipts whisper · what a headline number hides
Share count
−3.8%
67.8mn → 65.2mn diluted shares since FY21. Part of EPS growth is the shrinking denominator. Watch net income too.
Capex
$433.0M
+46.8% YoY in FY25 · 6.0% of revenue.
Returns vs FCF
85%
$435.0M returned vs $511.0M of FCF in FY25. Buybacks + dividends covered by cash flow.
What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)
10¢ of every revenue dollar becomes profit. The biggest cost lever is COGS.
Margin trend · direction beats level Gross Operating Net
Over this window: gross 19.3% → 25.3%. Net margin 10.1% is more than double the sector median.
The receipt · income statement · FY21–FY25 USD millions except per-share & ratios · hover a line for its definition
USD millions except per-share & ratios
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 7,191.0 | 7,219.0 | 7,430.0 | 8,160.0 | 7,946.0 | 6,894.0 | ▼2.8% | +1.2% |
Cost of revenue | 5,535.0 | 5,391.0 | 5,639.0 | 6,411.0 | 6,452.0 | 5,563.0 | ▼4.4% | −0.8% |
Gross profit | 1,656.0 | 1,828.0 | 1,791.0 | 1,749.0 | 1,494.0 | 1,331.0 | ▲2.1% | +8.3% |
Selling, general & admin | 833.0 | 815.0 | 782.0 | 789.0 | 715.0 | 668.0 | ▲4.2% | +5.1% |
Total operating expenses | 844.0 | 812.0 | 908.0 | 792.0 | 732.0 | 1,021.0 | ▼10.6% | −5.6% |
Operating incomefeeds ROC rank | 812.0 | 1,016.0 | 883.0 | 957.0 | 762.0 | 310.0 | ▲15.1% | +34.5% |
Other income, net | −42.0 | −42.0 | 48.0 | −118.0 | −94.0 | −62.0 | — | — |
Pretax income | 770.0 | 974.0 | 931.0 | 839.0 | 668.0 | 248.0 | ▲4.6% | +40.8% |
Income tax | 201.0 | 238.0 | 277.0 | 188.0 | 166.0 | 123.0 | ▼14.1% | +17.9% |
Net incomePiotroski ROA ✓feeds Buffett Quality owner earnings | 563.0 | 729.0 | 647.0 | 643.0 | 492.0 | 125.0 | ▲12.7% | +55.4% |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | 8.81 | 11.18 | 9.71 | 9.60 | 7.34 | 1.73 | ▲15.1% | +59.4% |
Diluted shares (mn) | 63.70 | 65.20 | 66.60 | 67.00 | 67.00 | 67.80 | ▼2.1% | −1.0% |
| Margins | ||||||||
Gross margin25th pct in Consumer Defensive | 23.0% | 25.3% | 24.1% | 21.4% | 18.8% | 19.3% | ▲1.2pp | +6.0pp |
Operating margin | 11.3% | 14.1% | 11.9% | 11.7% | 9.6% | 4.5% | ▲2.2pp | +9.6pp |
Net margin63rd pct in Consumer Defensive | 7.8% | 10.1% | 8.7% | 7.9% | 6.2% | 1.8% | ▲1.4pp | +8.3pp |
† TTM = trailing four quarters through 2026-09-30.FY21 effective tax rate was 50% vs a 25% norm for this window, likely a one-time item; see the filing.
5 more years of statements and CSV export are on Premium, and 13 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
These lines feed the tenet checklists: see which gates passTenets →Margins & returns continue as sector-ranked ratiosStatistics →
Annual report filed 2026-02-17 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Ingredion's revenue last fiscal year?
Ingredion reported revenue of $7,219.0M in fiscal 2025, down 2.8% from fiscal 2024.
What was Ingredion's net income?
Ingredion reported net income of $729.0M in fiscal 2025, a net margin of 10.1%.
Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

